Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma
NCT ID: NCT05548686
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
15 participants
INTERVENTIONAL
2022-11-30
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For many years, non-medicinal techniques have been proving their benefits and their central role in the treatment of chronic pain. Physical activity has been widely demonstrated in the literature to have considerable physical benefits (reduced risk of hypertension, vascular accidents, diabetes, improved bone condition, weight control, etc.) but also psychological benefits. However, according to the WHO, nearly 31% of adults aged 15 and over were not physically active in 2008. Physical inactivity is considered the 4th leading risk factor for death in the world. It is estimated to be the main cause of 21 to 25% of breast and colon cancers.
The investigators therefore propose a feasibility study, interventional, with minimal risks and constraints, evaluating the effectiveness of adapted physical activity in chronic pain related to a pathology little studied in this field of management: multiple myeloma. This study will include about 15 patients with residual pain 3 months after the end of their induction chemotherapy treatment.
Adapted Physical Activity sessions will be performed for 12 weeks. The evaluation of the expected benefits on pain and its consequences (cognitive, emotional, behavioral, physical ...) will be done through simple and validated questionnaires as well as on the evolution of the consumption of analgesics. The expected duration of the study will be one year.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
What Are the Brakes and Levers of Physical Activity Practice for Patients With Chronic Lower Back Pain?
NCT02466360
Influence of Physical Activity Level on Lumbar Movement Control
NCT05649150
Investigation of Immediate, Short and Long Term Effects of Mulligan Mobilization With Movement Techniques in Nonspesific Chronic Low Back Pain
NCT04802850
The Effects of Different Exercise Approaches in Patients With Chronic Low Back Pain
NCT04000685
Telerehabilitation-based Motor Imagery in Nonspecific Low Back Pain
NCT05049772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adapted Physical Activity
Patients benefiting from adapted physical activity
adapted physical activity
3 sessions of adapted physical activity per week during 12 weeks for each patient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
adapted physical activity
3 sessions of adapted physical activity per week during 12 weeks for each patient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have completed more than 3 months of induction chemotherapy for Multiple Myeloma.
* Patients not eligible for bone marrow transplantation.
* Patient able to read, understand French and self-assess their pain on the VAS
* Patient followed in the haematology department of the Caen University Hospital and living in Calvados
Exclusion Criteria
* Unstable angina
* Decompensated heart failure
* Complex ventricular rhythm disorders
* Severe uncontrolled hypertension
* PAH \> 60mmHg
* Presence of large or pedunculated intra-cavity thrombus
* Acute pericardial effusion
* Severe obstructive cardiomyopathy
* Tight and/or symptomatic aortic stenosis
* Recent thrombophlebitis with or without pulmonary embolism
* Diabetes with plantar perforating disease for activities involving the lower limbs
* Patient eligible for a bone marrow transplant.
* Patients with a major and/or potentially dangerous osteolytic lesion.
* Patients who do not meet the criteria for "moderate" functional impairment (assessed at the inclusion visit). defined by the HAS in 2019
* Pregnant or lactating woman.
* Minor patient.
* Patient under legal protection.
* Patient who does not read or understand French.
* Patient undergoing physiotherapy at the time of inclusion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02599-30
Identifier Type: REGISTRY
Identifier Source: secondary_id
20-163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.